MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, GILD made $6,960M in revenue. $2,021M in net income. Net profit margin of 29.04%.

Income Overview

Revenue
$6,960M
Net Income
$2,021M
Net Profit Margin
29.04%
EPS
$1.61
Unit: Million (M) dollars
Revenue Breakdown
    • Product
    • Royalty Contract And Other
Revenue Breakdown
    • US
    • Europe
    • Rest Of World

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Total revenues
6,960 7,925 7,769 7,082
Cost of goods sold
1,445 1,624 1,569 1,501
Research and development expenses
1,372 1,583 1,346 1,491
Acquired in-process research and development expenses
107 540 170 61
In-process research and development impairments
-400 0 190
Selling, general and administrative expenses
1,451 1,794 1,357 1,365
Total costs and expenses
4,374 5,941 4,442 4,608
Operating income
2,586 1,984 3,327 2,474
Interest expense
240 254 256 254
Other (income) expense, net
235 349 569 208
Income before income taxes
2,580 2,077 3,641 2,429
Income tax expense at u.s. federal statutory tax rate
-88* --
State taxes, net of federal benefit
--34* --
Tax rate differential-IE
--29* --
Other-IE
-0* --
Tax rate differential-Foreign Tax Jurisdiction Other
--2* --
Global intangible low-taxed income
-21* --
Foreign-derived intangible income
-21* --
U.s. taxation of foreign branches
-2* --
Other
-1* --
R&d tax credits
-36* --
Other
-2* --
Valuation allowance-US
--134* --
Acquired ipr&d and related charges
-16* --
Other
-5* --
Changes in unrecognized tax benefits
-15* --
Settlement of tax examinations
-0* --
Legal entity restructuring
-0* --
Other-US
-7* --
Income tax expense
559 -105 589 468
Net income
-2,183 3,052 1,960
Net loss attributable to noncontrolling interest
-0 0 0
Net income
2,021 2,183 3,052 1,960
Basic EPS
1.63 1.758 2.46 1.57
Diluted EPS
1.61 1.744 2.43 1.56
Basic Average Shares
1,242,000,000 1,242,000,000 1,243,000,000 1,245,000,000
Diluted Average Shares
1,254,000,000 1,252,000,000 1,254,000,000 1,255,000,000
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
US$4,926M (6.37%↑ Y/Y)Europe$1,137M (5.96%↑ Y/Y)Rest Of World$883M (-2.86%↓ Y/Y)Europe$8M (-27.27%↓ Y/Y)Rest Of World$6M (0.00%↑ Y/Y)Product$6,946M (5.04%↑ Y/Y)Royalty Contract AndOther$14M (-74.07%↓ Y/Y)Total revenues$6,960M (4.39%↑ Y/Y)Operating income$2,586M (15.60%↑ Y/Y)Other (income)expense, net$235M (171.65%↑ Y/Y)Total costs andexpenses$4,374M (-1.26%↓ Y/Y)Income before incometaxes$2,580M (56.46%↑ Y/Y)Interest expense$240M (-7.69%↓ Y/Y)Selling, general andadministrative expenses$1,451M (15.34%↑ Y/Y)Cost of goods sold$1,445M (-6.17%↓ Y/Y)Research and developmentexpenses$1,372M (-0.51%↓ Y/Y)Acquired in-processresearch and development...$107M (-57.71%↓ Y/Y)Net income$2,021M (53.69%↑ Y/Y)Income tax expense$559M (67.37%↑ Y/Y)

Gilead_Sciences_Logo-svg

GILEAD SCIENCES, INC. (GILD)

Gilead_Sciences_Logo-svg

GILEAD SCIENCES, INC. (GILD)